[Interferon, oligoadenylate synthetase and oligoadenine nucleotide--a cell biological triad]
- PMID: 1691881
[Interferon, oligoadenylate synthetase and oligoadenine nucleotide--a cell biological triad]
Abstract
In sensitive cells interferon (IFN) induces many genes leading to an increased production of several different proteins. One of these gene products is the enzyme oligoadenylatesynthetase (OAS). The main effect of this IFN induced enzyme activation is the production of oligonucleotides (2-5A) from cellular ATP. The 2-5A activates an endogeneous ribonuclease (RNase), which cleaves rRNA and mRNA. The sum of these effects is degradation of cellular and viral RNA, resulting in reduced protein synthesis. Taken together, IFN, OAS and 2-5A exist as a part of immune defence system primarily directed against virus infections. Furthermore, it is possible that this system under normal, physiological conditions regulates the growth of somatic cells. The virus inhibiting effect of IFN has been useful in the treatment of viral infections and certain types of cancer. Probably, the IFN dependent enzyme systems will achieve a greater therapeutic significance in the future.
Similar articles
-
[Induction of interferon-specific enzymes in cultures of cells sensitive and resistant to interferon].Mol Gen Mikrobiol Virusol. 1988 Feb;(2):34-9. Mol Gen Mikrobiol Virusol. 1988. PMID: 2453797 Russian.
-
VIP induces in HT-29 cells 2'5'oligoadenylate synthetase and antiviral state via interferon beta/alpha synthesis.Peptides. 1991 Sep-Oct;12(5):1085-93. doi: 10.1016/0196-9781(91)90064-v. Peptides. 1991. PMID: 1724797
-
Interferon stimulates the expression of 2',5'-oligoadenylate synthetase and MHC class I antigens in insulin-producing cells.J Interferon Res. 1991 Oct;11(5):255-60. doi: 10.1089/jir.1991.11.255. J Interferon Res. 1991. PMID: 1723088
-
2',5'-oligoadenylate synthetase in interferon-treated chick cells.Tex Rep Biol Med. 1981-1982;41:487-92. Tex Rep Biol Med. 1981. PMID: 6189213 Review.
-
Novel functions of proteins encoded by viral stress-inducible genes.Pharmacol Ther. 2004 Sep;103(3):245-59. doi: 10.1016/j.pharmthera.2004.07.007. Pharmacol Ther. 2004. PMID: 15464592 Review.